Bogart Wealth LLC grew its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 1.8% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 58,669 shares of the financial services provider's stock after buying an additional 1,042 shares during the period. CME Group accounts for approximately 0.7% of Bogart Wealth LLC's portfolio, making the stock its 27th largest position. Bogart Wealth LLC's holdings in CME Group were worth $16,170,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Heartland Bank & Trust Co purchased a new position in CME Group during the first quarter worth about $377,000. Catalyst Capital Advisors LLC raised its holdings in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock worth $971,000 after purchasing an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. purchased a new position in CME Group during the first quarter worth about $367,000. Fulcrum Equity Management purchased a new position in CME Group during the first quarter worth about $258,000. Finally, AIA Group Ltd raised its holdings in CME Group by 17.8% during the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock worth $4,416,000 after purchasing an additional 2,510 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at CME Group
In related news, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the sale, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the firm's stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,043 shares of company stock valued at $3,527,956 over the last three months. Company insiders own 0.30% of the company's stock.
Wall Street Analysts Forecast Growth
CME has been the topic of several recent analyst reports. UBS Group lowered their target price on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday, September 8th. Jefferies Financial Group lowered their target price on shares of CME Group from $313.00 to $304.00 and set a "buy" rating on the stock in a research report on Friday, October 10th. TD Cowen upped their target price on shares of CME Group from $281.00 to $288.00 and gave the stock a "hold" rating in a research report on Wednesday, October 8th. JPMorgan Chase & Co. upped their target price on shares of CME Group from $252.00 to $256.00 and gave the stock an "underweight" rating in a research report on Tuesday, October 14th. Finally, Weiss Ratings restated a "buy (b)" rating on shares of CME Group in a research report on Wednesday, October 8th. Seven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, CME Group presently has an average rating of "Hold" and a consensus price target of $283.71.
Read Our Latest Analysis on CME
CME Group Stock Up 2.1%
CME stock opened at $267.93 on Monday. The company's 50 day simple moving average is $267.30 and its 200-day simple moving average is $271.40. The firm has a market capitalization of $96.56 billion, a PE ratio of 25.94, a P/E/G ratio of 6.16 and a beta of 0.41. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business earned $2.56 earnings per share. Equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group's dividend payout ratio is currently 48.40%.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.